Sulpholipid immobilizing protein 1 (SLIP1) is an evolutionarily conserved 68 kDa plasma membrane protein, present selectively in germ cells. We have previously shown that mouse sperm SLIP1 is involved in sperm-zona pellucida (ZP) binding. In this report, we extended our study to the human system. Immunoblotting demonstrated that anti-SLIP1-reactive proteins (mol. wt 68 and 48 kDa) could be extracted from human spermatozoa by an ATPcontaining solution, a result that is consistent with observations in other species. Direct immunofluorescence, using Cy3-conjugated anti-SLIP1 IgG, revealed SLIP1 staining over the acrosomal region, with higher intensity at the posterior area. Using the human sperm-ZP binding assay, we demonstrated that pretreatment of human spermatozoa from three donors with anti-SLIP1 IgG revealed lower numbers of zona-bound spermatozoa, as compared to the corresponding control spermatozoa treated with normal rabbit serum IgG. This decrease in zona pellucida binding was not from an antibody-induced decline in sperm motility or an increase in the premature acrosome reaction. The results strongly suggest that anti-SLIP-reactive proteins on human spermatozoa play an important role in ZP binding.
Introduction
, and sulpholipidimmobilizing protein 1 (SLIP1) (Tanphaichitr et al., 1992 , Mammalian sperm-oocyte interaction that culminates in fertil-1993) . ization occurs in sequential steps, with sperm-zona pellucida Whereas sp56 appears to be rodent specific and the presence (ZP) binding being the initial event. The facts that mammalian and significance of galactosyltransferase on human sperm ZP consists of only a few glycoproteins and that ovarian ZP plasma membrane is still inconclusive (Tulsiani et al., 1990 ; can be isolated in quantity have facilitated studies on sperm- Huszar et al., 1997) , the cDNA coding sequence and the ZP binding, especially in the mouse system. Mouse and human derived peptide sequence of human tyrosine kinase (zona ZP3 and ZP2 glycoproteins have been shown to be the primary receptor kinase) have been reported (Burks et al., 1995) . receptor of acrosome-intact spermatozoa and the secondary Phosphorylation of a 95 kDa protein on the human sperm receptor of acrosome-reacted spermatozoa respectively (Bleil surface was also shown to increase after sperm exposure to et  recombinant human ZP3 (Brewis et al., 1998) . FA-1, a human Whitmarsh et al., 1996; Harris et al., 1999; Tsubamoto et al., sperm surface protein with apparent mol. wt of 23 and 51 kDa, 1999) . Unlike this simple situation on the ZP side, numerous has been demonstrated to be significant in human sperm-ZP ZP-associated receptors on spermatozoa have been described.
binding (Naz et al., 1984 Naz and Ahmad, 1994 ; Kadam In mice, these include sperm galactosyltransferase (Shur and et al., 1995) , and it is the human ZP3 protein to which FA-1 Hall, 1982a,b; Lopez et al., 1985; Miller et al., 1992b) , zona binds specifically (Naz and Ahmad, 1994) . Other human sperm receptor kinase (or p95) (Leyton and Saling, 1989a ; Burks surface proteins that are involved in ZP binding include P34H et al., 1995) , sp56 (Cheng et al., 1994; Bookbinder et al., 1995) , sperm trypsin inhibitor sensitive site (Saling, 1981; (Boue et al., 1994 (Boue et al., , 1996 , mannose lectin (Chen et al.,
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1995), core region peptides of an acrosomal serine protease inhibitor (Moore et al., 1993) and a YLP 12 -protein (72 kDa) Antibodies . As postulated in other species, all of the Anti-SLIP1, a rabbit polyclonal IgG antibody generated against rat sperm surface proteins that have been proposed to associate testis SLIP1 and purified by SGG affinity chromatography (Lingwood, with ZP may act simultaneously and synergistically and/or 1985) , and a rabbit polyclonal antiserum (IgG) directed against the sequentially (Wassarman, 1999) .
recombinant Mycoplasma hyopneumonia heat shock protein 74.5 SLIP1 (mol. wt~68 kDa) was first isolated from a rat testis (HSP74.5) (Boulanger et al., 1995) were provided by Dr C.Lingwood (Hospital for Sick Children, University of Toronto, Toronto, ON, homogenate by sulphogalactosylglycerolipid (SGG) affinity Canada). A Cappel normal rabbit serum (NRS) and rabbit polyclonal column chromatography (Lingwood, 1985) . Subsequently, it antiserum (IgG) generated against rat serum albumin (RSA), antiwas shown that a crude extract of SLIP1 can be prepared by RSA, were purchased from Organon Teknika Inc. (Scarborough, treating intact testicular cells or gametes (Law et al., 1988; ON, Canada) . A goat anti-rabbit immunoglobulin conjugated with Tanphaichitr et al., 1993; Ahnonkitpanit et al., 1999) proteins from intact cells (Carter and Hakomori, 1977) .
Previously described procedures were used to prepare IgG fraction Lingwood and his associates have further demonstrated that from anti-SLIP1 antiserum (Tanphaichitr et al., 1993) , to formylate rat testis SLIP1 can be purified from its AES crude extract to anti-SLIP1 IgG to reduce non-specific binding to spermatozoa (Lingwood, 1985) , to generate affinity-purified anti-SLIP1 IgG a single 68 kDa band on sodium dodecyl sulphate-polyacryl- (Ahnonkitpanit et al., 1999) , and to conjugate a fluorochrome, Cy3
amide gel electrophoresis (SDS-PAGE) (Lingwood and (excitation wavelength: 550 nm, emission wavelength: 565 nm), to Nutikka, 1991) . Using this purified SLIP1, we have shown anti-SLIP1 IgG and NRS IgG (Ahnonkitpanit et al., 1999) .
that the protein can bind to the oocyte ZP (Tanphaichitr et al., 1993) . Supporting the significance of SLIP1 in ZP binding are
Human sperm preparation the findings that SLIP1 was immunolocalized to the rat and
With approval from the Human Ethics Committee, Loeb Health mouse sperm head (Lingwood, 1986; Tanphaichitr et al., 1993) ,
Research Institute, Ottawa Hospital, freshly ejaculated human semen the site of ZP binding (Yanagimachi, 1994 (Tanphaichitr et al., tion criteria, 1999) . Motile spermatozoa were prepared from these 1992, 1993). Immunoblotting revealed that SLIP1 is present semen samples via discontinuous Percoll gradient centrifugation primarily in germ cells (both male and female) and to a lesser (Tanphaichitr et al., 1988 number of components including those that have the ability to extraction and direct immunofluorescence were also performed on bind to SGG and ZP (Lingwood, 1985; these spermatozoa following their washing in HTF without protein 1993, 1998), as well as albumin and a heat shock protein 70 supplementation.
(HSP70) (Boulanger et al., 1995; Tanphaichitr et al., 1998; our unpublished results) . However, the studies have indicated Extraction of SLIP1 from human spermatozoa that neither albumin nor HSP70 is involved in sperm-ZP SLIP1 was extracted from human spermatozoa with AES solution binding (Tanphaichitr et al., 1999) . Recently, we have described
(1 mmol/l ATP, 1 mmol/l EDTA, 340 mmol/l sucrose, 0.2 mmol/l N-a-p-tosyl-L-lysine chloromethylketone hydrochloride in 20 mmol/l the purification from pig sperm AES extract (SLIP1 crude Tris-HCl, pH 7.6), following the method described earlier for rat extract) of P68, which reacts with anti-SLIP1, but not anti-rat testis cells and mouse and pig spermatozoa, but omitting the ultraserum albumin (antiRSA) or an antibody against HSP70. Like centrifugation step (Law et al., 1988; Tanphaichitr et al., 1993, SLIP1, P68 binds SGG, and when it is included in an excess surface is involved in binding to the ZP.
against Milli-Q water (Millipore Canada, Nepean, ON, Canada) and anti-SLIP1 IgG-treated fraction was labelled with TRITC and the NRS-IgG-treated fraction with FITC). In another set of experiments, lyophilized.
FITC-labelled spermatozoa from donor 1 were also treated with SDS-PAGE and immunoblotting affinity-purified anti-SLIP1 IgG with 200 µg/ml non-affinity-purified anti-SLIP1 IgG (prepared in parallel with the affinity-purified anti-SDS-PAGE (10% polyacrylamide, 0.75 mm thick) (Laemmli, 1970) body). Following successive washing and resuspension in HTF-BSA, followed by immunoblotting (Towbin and Gordon, 1984) of sperm equal volumes of both sperm fractions were mixed and~200 000 AES extracts was performed, as previously described (Tanphaichitr spermatozoa from the mixture were incubated (5% CO 2 , 37°C, 4 h) et al., 1998). The nitrocellulose blot was blocked for at least 1 h with with each zona-intact oocyte in 1 ml HTF-BSA. Sperm-oocyte 5% fat-free milk in Tris-buffered saline (20 mmol/l Tris-HCl, complexes were washed three times in fresh HTF-BSA through a 137 mmol/l NaCl, pH 7.6) to reduce non-specific binding. Immunodrawn Pasteur pipette of a 200 µm bore size to eliminate loosely blotting was performed using formylated anti-SLIP1 antiserum (1:500 bound spermatozoa. Three to five sperm-oocyte complexes were then dilution), anti-RSA (1:1000 dilution), anti-HSP74.5 (1:1000 dilution) transferred to a slide, flattened gently by a coverslip (supported by a and NRS antiserum (1:500 dilution), all of which were diluted in dot of Nivea cream at each corner), and evaluated for the number of the blocking medium, and the secondary antibody, goat anti-rabbit spermatozoa bound to each ZP under a Zeiss IM35 epifluorescence immunoglobulin conjugated with horseradish peroxidase (1:3000 microscope. FITC-labelled spermatozoa and TRITC-labelled spermdilution). Antigen-antibody binding was detected by chemiluminesatozoa bound to the same zona were counted using the specific filters cence using an ECL kit (Amersham Canada Ltd., Oakville, ON, for fluorescein and rhodamine. Since numerous spermatozoa bound Canada).
to each ZP, only those that were in the same plane as the oocyte diameter were counted.
Immunofluorescence of spermatozoa
Approximately 200 000 spermatozoa were washed twice in PBS Assessment of the sperm acrosome status after anti-SLIP1 IgG (500 g, 25°C, 5 min). The sperm pellet was treated with 100 µg/ml treatment Cy3-anti-SLIP1 IgG in PBS or in PBS-1% BSA or with affinityCapacitated human spermatozoa treated with anti-SLIP1 IgG or NRS purified Cy3-anti-SLIP1 IgG (5% CO 2 , 37°C, 30 min), washed twice IgG, as described in the gamete binding section, were assessed for in PBS (500 g, 25°C, 5 min), mounted onto a glass slide and viewed their viability and acrosome integrity following a published method under a Zeiss IM35 epifluorescence microscope. Spermatozoa exposed (Aitken et al., 1993) . Spermatozoa were defined as viable by to Cy3-NRS IgG in place of Cy3-anti-SLIP1 IgG served as negative their swollen tails following exposure to a hypo-osmotic solution controls. The staining pattern of at least 200 spermatozoa was (Jeyendran et al., 1984) . The acrosome intactness was demonstrated observed for each sample.
by complete staining of the acrosome after the spermatozoa were Separate aliquots of human spermatozoa prepared as described fixed in ice-cold methanol and treated with FITC-conjugated Pisum above were also incubated with anti-RSA antiserum (1:40 dilution sativum agglutinin (PSA; Sigma Chemical Co.) (Cross et al., 1986) . In in PBS), anti-HSP74.5 (1:30 dilution in PBS) and NRS IgG contrast, acrosome-reacted spermatozoa showed FITC-PSA staining in (100 µg/ml) under the same conditions as used for Cy3-anti-SLIP1 the equatorial segment only, whereas acrosome-reacting spermatozoa IgG. After successive washes in PBS, the sperm samples were displayed partial or patchy staining of the apical segment of the incubated (30 min, 25°C) with Cy3-conjugated goat anti-rabbit IgG acrosome along with complete staining of the equatorial segment. (5 µg/ml). The spermatozoa were then washed to remove excess To test the acrosome reaction inducibility, spermatozoa pretreated unbound fluorescent secondary antibody and viewed under the Zeiss or untreated with anti-SLIP1 IgG were incubated in HTF-BSA, and epifluorescence microscope. then exposed to 2.5 µmol/l A23187 [Calbiochem-Novabiochem Co., La Jolla, CA, dissolved in 0.025% dimethylsulphoxide (DMSO)], or Human sperm-zona pellucida binding to 0.025% DMSO alone. After the treatment, the sperm samples were The human sperm-ZP binding was performed following a published subjected to the hypo-osmotic test and FITC-PSA staining (Aitken method (Liu et al., 1988) . The human oocytes used in this assay et al., 1993). were those that had failed fertilization in the Human In Vitro Approximately 200 viable spermatozoa were assessed for acrosomal Fertilization Program, Ottawa Hospital -Civic Campus, and were integrity in each treatment. donated by the patients for research purposes, with the approval of the Research Ethics Board, Ottawa Hospital. These oocytes were Assessment of sperm motility after anti-SLIP1 IgG treatment stored in a high-salt buffer containing 2 mol/l ammonium sulphate, Motility of Percoll gradient centrifuged spermatozoa, treated with 0.5% dextran and 40 mmol/l HEPES, pH 7.4 (Moore et al., 1993) anti-SLIP1 IgG or NRS IgG (see the gamete binding section), as well until use. On the experimental day, the salt-stored oocytes were as that of untreated spermatozoa, was assessed using an automated washed five times and incubated (5% CO 2 , 37°C, 1 h for each wash) HTM-S Motility Analyzer, version 7 (Hamilton-Thorn Research Inc., in 1 ml HTF-BSA before co-incubation with spermatozoa, prepared Danvers, MA, USA). The analyser was set to analyse motility as described below.
parameters in 16 frames at 30 frames/s for each field. The motility Spermatozoa resuspended in HTF-BSA at 10ϫ10 6 motile parameters analysed included average path velocity (VAP, µm/s), spermatozoa/ml were divided into two fractions, one being labelled mean tract speed (VCL, µm/s), progressive velocity (VSL, µm/s), with fluorescein isothiocyanate (FITC; Sigma Chemical Co.) and the mean linearity (LIN, %), mean straightness (STR, %), amplitude of other with tetramethylrhodamine isothiocyanate (TRITC) (Sigma lateral head displacement (ALH, µm) and mean beat frequency Chemical Co.) as described previously (Liu et al., 1988) . The FITC-(BCF, Hz). labelled spermatozoa and the TRITC-labelled spermatozoa were treated (5% CO 2 , 37°C, 30 min) with 100 µg/ml anti-SLIP1 IgG Statistical analysis and NRS IgG (negative control) respectively. In order to ensure that the results obtained from this binding study were not due to the Freidman χ 2 r -test was used to compare the percentages of the acrosome reaction among the anti-SLIP1 IgG-treated sample and the fluorochrome effects, the two fluorochromes were switched between the two IgG-treated sperm fractions in alternate experiments (i.e., the control samples (NRS-IgG, dimethylsulphoxice and A23187 treated 
serum (NRS) (B). The loaded human AES extracts were from
Bar ϭ 10 µm. Note that anti-SLIP1-reactive antigens were 50ϫ10 6 spermatozoa of each donor. AES extract from boar localized only to the surface overlying the acrosome, with the spermatozoa (10 µg) and P68 purified from boar sperm AES highest distribution in the posterior region of the acrosome. extract (0.3 µg) (Tanphaichitr et al., 1998) were co-electrophoresed for comparison. Positions of mol. wt markers on sodium dodecyl sulphate-polyacrylamide gel electrophoresis were indicated by arrows on the left. SLIP1-reactive bands with faster electrophoretic mobility (mol. wt~55 and 48 kDa) were also present in the boar sperm AES spermatozoa). The same test was also employed to compare the extract (Figure 1 ). Since formylated anti-SLIP1 still crossmotility parameters of spermatozoa after anti-SLIP1 IgG, NRS IgG reacts with albumin, also of 68 kDa mol. wt, when present at treatment and no treatment. A paired t-test was performed to compare Ͼ1 µg on nitrocellulose, and since albumin could be coating the effect of sperm pretreatment with anti-SLIP1 IgG or NRS IgG the ejaculated spermatozoa (Tanphaichitr et al., 1998) , the on human sperm-ZP binding within the same experiment. Two-way nitrocellulose blot of these human AES extracts was reprobed analysis of variance (ANOVA) was used for the same comparison with anti-RSA. The results indicated the absence of albumin among several experiments. P Ͻ 0.05 was considered to be statistically in these AES extracts obtained from the human sperm samples, significant. which had been washed extensively in PBS (data not shown). Reprobing was also performed with anti-HSP74.5 for the Results similar reason that cross-reactivity of anti-SLIP1 to rat testis HSP70 has previously been described (Boulanger et al., 1995) . AES is able to extract SLIP1 from mouse and boar spermatozoa and testis cells from various mammals and vertebrates Again, no anti-HSP74.5-reactive bands were observed on the blot of human sperm AES extracts (data not shown). (Lingwood, 1985; Law et al., 1988; Tanphaichitr et al., 1993 Tanphaichitr et al., , 1998 . Using anti-SLIP1, immunoblotting of the sperm AES Direct immunofluorescence of live human spermatozoa with Cy3-anti-SLIP1 IgG diluted in either PBS or PBS-BSA (to extract from three donors shows that SLIP1 (mol. wt~68 kDa, reactive with anti-SLIP1) was present in human spermatozoa block any cross-reactivity of anti-SLIP1 with albumin on the sperm surface) revealed that Ͼ95% of spermatozoa exhibited (Figure 1) . Donor 3 appeared to possess the highest amount of intact SLIP1, as compared to donors 1 and 2. In contrast, an fluorescent staining over the acrosome with the highest intensity at the posterior region of the acrosome (Figure 2 ). In contrast, additional anti-SLIP1-reactive protein band (mol. wt~48 kDa), possibly a processed product or a precursor of SLIP1, was another aliquot of these live human spermatozoa, which were incubated with Cy3-NRS IgG under the same conditions as present in both donors 1 and 2. It was noted that two anti- VAP ϭ average path velocity; VCL ϭ mean tract speed; VSL ϭ b Although the concentration of the affinity-purified anti-SLIP1 IgG was not progressive velocity; LIN ϭ mean linearity; STR ϭ mean straightness; known, the non-affinity-purified anti-SLIP1 IgG that was processed in ALH ϭ amplitude of lateral head displacement; BCF ϭ mean beat parallel but exposed to a blank nitrocellulose strip (see Materials and frequency. methods) amounted to 200 µg/ml. SLIP1 ϭ sulpholipid immobilizing protein 1; NRS ϭ normal rabbit serum.
those used for Cy3-anti-SLIP1 IgG, did not show any fluoresspecificity of anti-SLIP1-induced inhibition of gamete binding was due to the reaction of the antibody proteins on the sperm cent staining (Figure 2) . The results therefore indicated that the fluorescent staining observed specifically represented antisurface that participated in human ZP binding. The decrease in human sperm-ZP binding following sperm SLIP1-reactive protein(s). Indirect immunoflourescence studies using anti-RSA or anti-HSP74.5 and Cy3-secondary antibody pretreatment with anti-SLIP1 IgG was not due to the inhibitory effects of the antibody on sperm motility nor to an increase revealed no fluorescent staining on live human spermatozoa (data not shown), indicating the absence of an albumin-like in the acrosome reaction induced by immuno-aggregation of SLIP1. Results presented in Table II indicated that all motility protein and a HSP70 on the sperm surface.
Using the sperm-ZP binding assay (Liu et al., 1988) , we parameters (i.e. % motility, VAP, VCL, VSL, % LIN, % STR, ALH and BCF) of spermatozoa treated with anti-SLIP1 IgG demonstrated the role of human sperm SLIP1 in this binding event. Since the number of human oocytes and the amount of and NRS IgG were not significantly different from each other or from untreated spermatozoa incubated in parallel in medium anti-SLIP1 available to us were limited, spermatozoa from the same three donors used for SDS-PAGE/immunoblotting (Table II) . Although there were decreasing trends of some parameters (i.e. VCL and ALH) and increasing trends of % analysis were pretreated with only one concentration of anti-SLIP1 IgG, i.e. 100 µg/ml (experiments I, III and IV, Table I ), LIN and BCF after the antibody treatment, these changes were not significant among the three groups. The results indicated which exhibited maximum inhibition of mouse sperm-ZP binding (Tanphaichitr et al., 1993) . Although the number of that the decrease in human sperm-ZP binding following preexposure of spermatozoa to 100 µg/ml anti-SLIP1 IgG (Table I ) control spermatozoa (treated with 100 µg/ml NRS IgG in place of anti-SLIP1 IgG) bound to each ZP varied significantly from was not attributed to a decline in sperm motility. Spermatozoa from donor 1 treated with 200 µg/ml anti-SLIP1 IgG also one experiment to another (ranging from 15-30 spermatozoa per ZP, P Ͻ 0.0001, two-way ANOVA), the anti-SLIP1 IgGshowed the same motility parameters as the control spermatozoa exposed to 200 µg/ml NRS IgG (data not shown). In treated spermatozoa consistently bound to each ZP at a lower number than their corresponding controls in all three addition, pretreatment of human spermatozoa with 100 µg/ml anti-SLIP1 IgG did not induce the spontaneous acrosome experiments (P Ͻ 0.0001, paired t-test; Table I ). The degree of sperm-ZP inhibition caused by sperm pretreatment with reaction above the values observed in the negative control (i.e. spermatozoa treated with 100 µg/ml NRS IgG). More than 90% 100 µg/ml anti-SLIP1 IgG ranged from 49-87%. In order to further substantiate that the blocking of sperm binding to the of anti-SLIP1-treated human spermatozoa remained acrosome intact and were expected to bind to the human ZP to the same ZP by anti-SLIP1 was due to the specific masking of the ZP binding component of SLIP1, anti-SLIP1 IgG affinity-purified degree as the control (untreated or NRS IgG-treated sperm).
On the other hand, spermatozoa from these donors retained against pig sperm P68 (which has been shown to have direct ZP binding ability and to be devoid of albumin and HSP7) the ability to undergo the acrosome reaction following treatment with 2.5 µmol/l A23187 at~50% of the total population, as (Tanphaichitr et al., 1998) was also used for treatment of spermatozoa from donor 1. Results listed in Table I indicated described previously (Aitken et al., 1993) , whether they were untreated (data not shown) or pretreated with anti-SLIP1 IgG that affinity-purified anti-SLIP1 IgG (experiment IIb) inhibited human sperm-ZP binding to the same degree as the non-( Figure 3 ). All of these results (Tables I and II and Figure 3) taken together strongly suggested that human sperm SLIP1 affinity-purified anti-SLIP1 IgG (experiment IIa) that was used for affinity purification. All of these results suggested that the was involved in ZP binding.
cent staining on the surface of human spermatozoa that were exposed to anti-RSA and anti-HSP74.5 with subsequent incubation with a fluorescent secondary antibody. Although a HSP70 or albumin or an albumin-like protein (e.g., testibumin) present in the seminal plasma and epididymal fluid (Cheng and Bardin, 1986; Miller et al., 1992a ) is expected to be absorbed onto the sperm surface, it would have been removed by the Percoll gradient centrifugation employed in our human sperm preparation. Localization of anti-SLIP1-reactive antigens to only the acrosomal region of the human sperm head surface (Figure 2 ) supported our argument that human sperm SLIP1, like mouse Figure 3 . Lack of effects of sperm treatment with antisperm SLIP1 (Tanphaichitr et al., 1993 (Tanphaichitr et al., , 1992 (Tanphaichitr et al., , 1998 (Leyton and Saling, 1989b) to the sperm head anterior region take place (Moore et al., 1987; Aarons et al., 1991; Macek The presence of SLIP1 (68 kDa) as shown by its reactivity with anti-SLIP1 in human spermatozoa confirms previous et al., 1991; McKinnon et al., 1991; Wolf et al., 1992; Moase et al., 1997) . For a number of these ZP binding proteins, this results describing the evolutionary conservation of SLIP1 in male germ cells, as it exists in various vertebrate classes aggregation and relocalization, as mimically induced by their bi/multivalent antibodies, leads to sperm exocytosis (the acroranging from mammals to birds and fish (Law et al., 1988) . The slight possibility that this 68 kDa anti-SLIP1-reactive some reaction), implying that these proteins may regulate sperm signalling events (Aarons et al., 1991 ; Macek et al., band was albumin or HSP70 (due to the cross-reactivity of anti-SLIP1 with these two proteins when present at a microgram 1991; McKinnon et al., 1991) . However, this was not the case for either human sperm SLIP1 or mouse sperm SLIP1 amount on nitrocellulose) was completely ruled out by the absence of an anti-RSA or anti-HSP74.5-reactive band on the (Tanphaichitr et al., 1993; Moase et al., 1997) since capacitated spermatozoa of these two species remained acrosome intact Western blot of these human AES extracts. The presence of additional anti-SLIP1 bands (48 kDa) may plausibly be due following treatment with anti-SLIP1 IgG, suggesting that SLIP1 may be involved only in ZP affinity and not the to these bands being proteolytic products or precursors of SLIP1 (68 kDa). This 48 kDa band, along with additional downstream sperm signal transduction. Participation of anti-SLIP1-reactive proteins on the human bands, was also present in the boar sperm AES extract, indicating a common property of anti-SLIP1-reactive proteins sperm surface in ZP binding was demonstrated by the in-vitro human sperm-human ZP binding assay, using sperm pretreated in the two species. Nonetheless, it cannot be ruled out that these additional anti-SLIP1-reactive bands (including the with anti-SLIP1 IgG. Consistently, decreased numbers of spermatozoa bound per ZP were observed with spermatozoa 48 kDa one) may be proteins, which possess different peptide sequences but yet contain some common epitopes with SLIP1.
Discussion
from the three donors that were exposed to 100 µg/ml anti-SLIP1 IgG, although the degree of the decreases appeared to Like SLIP1 from male germ cells of other species (Law et al., 1988) , human sperm anti-SLIP1-reactive proteins were be varied among the three donors. The reasons for this variation are still unclear. Besides the possibility that the quality of the extractable with AES (Figure 1 ). AES has been used previously to extract peripheral plasma membrane proteins (Carter and failed fertilization oocytes used for each donor may be varied, the amount of anti-SLIP1-reactive proteins may also differ Hakomori, 1977) . Therefore, our results indicate that anti-SLIP1-reactive proteins originated from the sperm surface, from one donor to another. Based on the proposal that the redundant ZP receptors on the sperm surface may serve as and this was confirmed by our immunofluorescence studies, which revealed the presence of fluorescent staining of antiback-ups/surrogates for one another (Wassarman, 1999) , those sperm samples having lower amounts of SLIP1 may be SLIP1-reactive protein(s) on the surface of the live human sperm heads. Since Cy3-anti-SLIP1 affinity-purified against compensated by other ZP binding proteins. These spermatozoa would show less inhibition in ZP binding when treated with P68 (which has ZP binding ability and is devoid of an albuminlike protein and a HSP70) was also used in this fluorescent anti-SLIP1 IgG. In donor 1, we also demonstrated that inhibition of human sperm-ZP binding induced by anti-SLIP1 IgG study, the fluorescent pattern obtained was representative of the antigen that was expected to have ZP affinity. The absence occurred in a concentration-dependent manner. And since the inhibition of human sperm-ZP binding occurred at the same of an albumin-like protein and a HSP70 on the surface of human spermatozoa was also confirmed by the lack of fluoreslevel when either anti-SLIP1 IgG affinity-purified against P68
